Rachel Bernard1, Irtiqa Fazili2, Seesandra V Rajagopala3, Suman R Das4, Girish Hiremath1. 1. Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Monroe Carrell Jr Vanderbilt Children's Hospital, Nashville, Tennessee, USA. 2. University of Tennessee Health Science Center, Memphis, Tennessee, USA. 3. Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA. 4. Department of Otolaryngology and Department of Pathology Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Abstract
BACKGROUND: Esophageal conditions result in significant morbidity and mortality worldwide. There is growing enthusiasm for discerning the role of microbiome in esophageal diseases. Conceivably, the focus has been on examining the role of local microbiome in esophageal diseases although this is somewhat limited by the invasive approach required to sample the esophageal tissue. Given the ease of sampling the oral cavity combined with the advances in genomic techniques, there is immense interest in discovering the role of the oral microbiome in esophageal conditions. SUMMARY: In this review, we aim to discuss the current evidence highlighting the association between the oral microbiome and esophageal diseases. In particular, we have focused on summarizing the alterations in oral microbiome associated with malignant, premalignant, and benign esophageal cancers, inflammatory and infectious conditions, and esophageal dysmotility diseases. Identifying alterations in the oral microbiome is a key to advancing our understanding of the etiopathogenesis and progression of esophageal diseases, promoting novel diagnostics, and laying the foundation for personalized treatment approaches. KEY MESSAGES: Further studies are needed to unravel the mechanisms by which the oral microbiome influences the development and progression of esophageal diseases, as well as to investigate whether alterations in the oral microbiome can impact the natural history of various esophageal diseases.
BACKGROUND: Esophageal conditions result in significant morbidity and mortality worldwide. There is growing enthusiasm for discerning the role of microbiome in esophageal diseases. Conceivably, the focus has been on examining the role of local microbiome in esophageal diseases although this is somewhat limited by the invasive approach required to sample the esophageal tissue. Given the ease of sampling the oral cavity combined with the advances in genomic techniques, there is immense interest in discovering the role of the oral microbiome in esophageal conditions. SUMMARY: In this review, we aim to discuss the current evidence highlighting the association between the oral microbiome and esophageal diseases. In particular, we have focused on summarizing the alterations in oral microbiome associated with malignant, premalignant, and benign esophageal cancers, inflammatory and infectious conditions, and esophageal dysmotility diseases. Identifying alterations in the oral microbiome is a key to advancing our understanding of the etiopathogenesis and progression of esophageal diseases, promoting novel diagnostics, and laying the foundation for personalized treatment approaches. KEY MESSAGES: Further studies are needed to unravel the mechanisms by which the oral microbiome influences the development and progression of esophageal diseases, as well as to investigate whether alterations in the oral microbiome can impact the natural history of various esophageal diseases.
Authors: Andres Gomez; Josh L Espinoza; Derek M Harkins; Pamela Leong; Richard Saffery; Michelle Bockmann; Manolito Torralba; Claire Kuelbs; Rohith Kodukula; Jason Inman; Toby Hughes; Jeffrey M Craig; Sarah K Highlander; Marcus B Jones; Chris L Dupont; Karen E Nelson Journal: Cell Host Microbe Date: 2017-09-13 Impact factor: 21.023
Authors: James J Farrell; Lei Zhang; Hui Zhou; David Chia; David Elashoff; David Akin; Bruce J Paster; Kaumudi Joshipura; David T W Wong Journal: Gut Date: 2011-10-12 Impact factor: 23.059
Authors: Koji Atarashi; Wataru Suda; Chengwei Luo; Takaaki Kawaguchi; Iori Motoo; Seiko Narushima; Yuya Kiguchi; Keiko Yasuma; Eiichiro Watanabe; Takeshi Tanoue; Christoph A Thaiss; Mayuko Sato; Kiminori Toyooka; Heba S Said; Hirokazu Yamagami; Scott A Rice; Dirk Gevers; Ryan C Johnson; Julia A Segre; Kong Chen; Jay K Kolls; Eran Elinav; Hidetoshi Morita; Ramnik J Xavier; Masahira Hattori; Kenya Honda Journal: Science Date: 2017-10-20 Impact factor: 47.728
Authors: Brandilyn A Peters; Jing Wu; Zhiheng Pei; Liying Yang; Mark P Purdue; Neal D Freedman; Eric J Jacobs; Susan M Gapstur; Richard B Hayes; Jiyoung Ahn Journal: Cancer Res Date: 2017-12-01 Impact factor: 12.701
Authors: Xiaozhou Fan; Brandilyn A Peters; Eric J Jacobs; Susan M Gapstur; Mark P Purdue; Neal D Freedman; Alexander V Alekseyenko; Jing Wu; Liying Yang; Zhiheng Pei; Richard B Hayes; Jiyoung Ahn Journal: Microbiome Date: 2018-04-24 Impact factor: 14.650
Authors: Ikenna C Okereke; Aaron L Miller; Catherine F Hamilton; Adam L Booth; Gabriel L Reep; Clark L Andersen; Sandy T Reynolds; Richard B Pyles Journal: Sci Rep Date: 2019-07-15 Impact factor: 4.379
Authors: Xingdong Chen; Björn Winckler; Ming Lu; Hongwei Cheng; Ziyu Yuan; Yajun Yang; Li Jin; Weimin Ye Journal: PLoS One Date: 2015-12-07 Impact factor: 3.240
Authors: Victor D Plat; Tessel M van Rossen; Freek Daams; Nanne K de Boer; Tim G J de Meij; Andries E Budding; Christina M J E Vandenbroucke-Grauls; Donald L van der Peet Journal: Dis Esophagus Date: 2022-08-13 Impact factor: 2.822